Dennis A. Ausiello, Director at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 47,765 shares at $442.66 ($20.9M) on 2025-08-14, disclosed to the SEC on 2025-08-15.
Scheduled sale ($20.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $430.81 | 1,985 | $855K | 4.1% |
| 2 | $430.81 | 1,985 | $855K | 4.1% |
| 3 | $432.94 | 1,938 | $839K | 4.0% |
| 4 | $432.94 | 1,938 | $839K | 4.0% |
| 5 | $434.50 | 2,098 | $912K | 4.4% |
| 6 | $435.40 | 7,675 |
| $3.3M |
| 16.0% |
| 7 | $436.00 | 5,358 | $2.3M | 11.2% |
| 8 | $437.56 | 1,922 | $841K | 4.0% |
| 9 | $437.56 | 1,922 | $841K | 4.0% |
| 10 | $438.34 | 2,086 | $914K | 4.4% |
| 11 | $438.34 | 2,086 | $914K | 4.4% |
| 12 | $439.27 | 5,302 | $2.3M | 11.2% |
| 13 | $439.27 | 5,302 | $2.3M | 11.2% |
| 14 | $440.54 | 1,238 | $545K | 2.6% |
| 15 | $440.54 | 1,238 | $545K | 2.6% |
| 16 | $441.88 | 1,205 | $532K | 2.6% |
| 17 | $441.88 | 1,205 | $532K | 2.6% |
| 18 | $442.66 | 641 | $284K | 1.4% |
| 19 | $442.66 | 641 | $284K | 1.4% |
| Total | $436.92 avg | 47,765 | $20.9M | 100% |
| Filing → |
| ALNY | SELL | 2018-03-14 | $2.6M | — | Filing → |
| ALNY | SELL | 2017-11-03 | $2.6M | — | Filing → |
| ALNY | SELL | 2015-04-23 | $1.1M | — | Filing → |